Support our work
Decorative header background

A prediction model for electroconvulsive therapy effectiveness in patients with major depressive disorder from the Dutch ECT Consortium (DEC)

Publication year 2024
Published in Molecular Psychiatry
Authors Dore Loef, Adriaan W Hoogendoorn, Metten Somers, Roel J T Mocking, Dominique S Scheepens, Karel W F Scheepstra, Maaike Blijleven, Johanna M Hegeman, Karen S van den Berg, Bart Schut, Tom K Birkenhager, Willemijn Heijnen, Didi Rhebergen, Mardien L Oudega, Sigfried N T M Schouws, Eric van Exel, Bart P F Rutten, Birit F P Broekman, Anton C M Vergouwen, Thomas J C Zoon, Rob M Kok, Karina Somers, Esmée Verwijk, Jordy J E Rovers, Gijsbert Schuur, Jeroen A van Waarde, Joey P A J Verdijk, Dieneke Bloemkolk, Frank L Gerritse, Hanneke van Welie, Bartholomeus C M Haarman, Sjoerd M van Belkum, Maurice Vischjager, Karin Hagoort, Edwin van Dellen, Indira Tendolkar, Philip F P van Eijndhoven, Annemiek Dols

Reliable predictors for electroconvulsive therapy (ECT) effectiveness would allow a more precise and personalized approach for the treatment of major depressive disorder (MDD). Prediction models were created using a priori selected clinical variables based on previous meta-analyses. Multivariable linear regression analysis was used, applying backwards selection to determine predictor variables while allowing non-linear relations, to develop a prediction model for depression outcome post-ECT (and logistic regression for remission and response as secondary outcome measures). Internal validation and internal-external cross-validation were used to examine overfitting and generalizability of the model's predictive performance. In total, 1892 adult patients with MDD were included from 22 clinical and research cohorts of the twelve sites within the Dutch ECT Consortium. The final primary prediction model showed several factors that significantly predicted a lower depression score post-ECT: higher age, shorter duration of the current depressive episode, severe MDD with psychotic features, lower level of previous antidepressant resistance in the current episode, higher pre-ECT global cognitive functioning, absence of a comorbid personality disorder, and a lower level of failed psychotherapy in the current episode. The optimism-adjusted R² of the final model was 19%. This prediction model based on readily available clinical information can reduce uncertainty of ECT outcomes and hereby inform clinical decision-making, as prompt referral for ECT may be particularly beneficial for individuals with the above-mentioned characteristics. However, despite including a large number of pretreatment factors, a large proportion of the variance in depression outcome post-ECT remained unpredictable.

Support our work!

The Friends Foundation facilitates groundbreaking brain research. You can help us with that.

Support our work